Developmental Funds are used to foster outstanding cancer research. During the last grant period, Developmental Funds provided essential support for eight outstanding new investigators, supported 31 pilot studies, and helped establish three new Shared Resources. In particular. Developmental Funds helped to strengthen the Division of Public Health Science and Improved interactions between this division and the Divisions of Basic and Clinical Sciences. During the next grant period, CINJ will use Developmental Funds to continue to enhance each of the established research Programs of the center: Cell Death and Survival Signaling;Genomic Instability and Tumor Progression;Cancer Pharmacology and Preclinical Therapeutics;Clinical Investigations;Carcinogenesis and Chemoprevention;and Cancer Prevention and Control. To accomplish this aim. Developmental Funds will be used to help recruit new investigators, develop new Shared Resources, and fund additional pilot projects aimed at fostering transdisciplinary and translational collaborations, within four major CINJ strategic initiatives: (1) to enhance translational research;(2) to enhance basic science depth through collaborative activity with consortium members;(3) to enhance bioinformatics and systems biology through strategic recruitment of bioinformatics and integration of computational biology faculty;and (4) to develop population science research through recruitment and pilot awards, and the incorporation of the State's cancer registry and research into CINJ. The identification of opportunities for developmental funds that are high yield, and possibly high risk, are developed by the Scientific Council, with advice from the internal and External Advisory Boards (see also Section 7.4). We are requesting a total of $600,000 per year in the Developmental Funds category from the CCSG. Specifically, we are requesting $150,000 toward recruitment and support of new faculty level scientists in areas of strategic need;(2) $225,000 to support pilot projects in high-priority and translational research areas;and (3) $225,000 to develop new Shared Resources ($75,000 each for Small Animal Imaging, Metabolomics, and Epidemiology Services) that align with CINJ's scientific growth and needs.

Public Health Relevance

Developmental Funds are critical to a dynamic cancer center as they offer a strong source of support for emerging research initiatives and related Infrastructure. Validation by the CCSG process of plans for the use of Developmental Funds helps garner additional

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Medicine & Dentistry of NJ
United States
Zip Code
Zhu, Sining; Jin, Juan; Gokhale, Samantha et al. (2018) Genetic Alterations of TRAF Proteins in Human Cancers. Front Immunol 9:2111
Perekatt, Ansu O; Shah, Pooja P; Cheung, Shannon et al. (2018) SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium. Cancer Res 78:4878-4890
Llanos, Adana A M; Tsui, Jennifer; Rotter, David et al. (2018) Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women. BMC Womens Health 18:162
Hadigol, Mohammad; Khiabanian, Hossein (2018) MERIT reveals the impact of genomic context on sequencing error rate in ultra-deep applications. BMC Bioinformatics 19:219
Severson, Eric A; Riedlinger, Gregory M; Connelly, Caitlin F et al. (2018) Detection of clonal hematopoiesis of indeterminate potential in clinical sequencing of solid tumor specimens. Blood 131:2501-2505
Shih, Weichung Joe; Lin, Yong (2018) Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers. Stat Med 37:687-709
Ding, Qiang; Gaska, Jenna M; Douam, Florian et al. (2018) Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease. Proc Natl Acad Sci U S A 115:E6310-E6318
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Modi, Parth K; Wang, Ye; Kirk, Peter S et al. (2018) The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications. Urology 117:50-56
Dai, Zhuqing; Feng, Simin; Liu, Anna et al. (2018) Anti-inflammatory effects of newly synthesized ?-galacto-oligosaccharides on dextran sulfate sodium-induced colitis in C57BL/6J mice. Food Res Int 109:350-357

Showing the most recent 10 out of 775 publications